Skip to main content
Premium Trial:

Request an Annual Quote

Geisinger Joins Penn Cancer Alliance Bioinformatics Consortium

NEW YORK, Aug. 2 (GenomeWeb News) - Geisinger Health System has joined the Pennsylvania Cancer Alliance Bioinformatics Consortium, Geisinger said today.

 

Gesinger patients will now be able to donate leftover tissues for biopsies to the Geisinger Biospecimen Bank, a Pennsylvania statewide data bank open to any consortium researcher.

 

The Pennsylvania Cancer Alliance Bioinformatics Consortium is a collaborative dedicated to "reducing the burden of cancer in the citizens of Pennsylvania by collecting, analyzing, and sharing tissue sample information among cancer researchers," Geisinger said in a statement.

 

Other participants in the consortium include the University of Pittsburgh Cancer Institute, Thomas Jefferson University's Kimmel Cancer Center, Fox Chase Cancer Center, University of Pennsylvania's Abramson Cancer Center, the Wistar Institute, Drexel University, Penn State Cancer Institute, and the Windber Research Institute.

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.